Member Info for ratcliffewriter

The wigwammer I'd pay no attention to anything Ivy says on this board. He proclaimed on t'other side that this board is 'a continual pat on the back “ glee club” with no place for any balanced and informative discussion.' He's not sought to clarify or withdraw this comment so I suggest the contempt be reciprocated unless some explanation is forthcoming.

A big endorsement of the science and its success is not in who says what here, but in seeing who is absent.

TD may be paid for, but have to be totally factual - can you imagine with some companies if they relied on quotes from management about a product that wasn't backed up by data? However within this I think it worth remembering that sclp management are renowned for very much 'fact only' pr - 'partial response' and not ''over 30 percent shrinkage."
So imo when the CEO uses the term 'unprecdented', it's probably worth paying attention to what come along next. (Other non-share influencing happy clapping opinions are also available which may cause spikes without affecting the sp of course)

I can't see why Ivy is bothering to post on a board he describes as 'a continual pat on the back “ glee club” with no place for any balanced and informative discussion.'
I doubt his sporadic contributions are realky intended to add much with that attitude.

Don't worry about being happy clappy wtp, AB says it won't affect the share price apart from causing spikes.

So from your posts today we have learnt that the sp shot up because the bb 'overpromised', but the bb has no effect on the sp.
That's all bases covered then, well done.

Interesting that you feel the bb has such an influence on the share price.

Got to give him credit for trying I suppose.

One cannot help but wonder if the fact covidity has been successful and is available to outside interest (as always stated I believe) will cause certain parties to react as in Matthew 8:12.

In my last, for chester read crumbs.

Excellent news - also of interest is 'NO side effects', and as you rightly point out there are a number who had completely written off covidity because the results were perhaps 10 working days later than they expected. They also ignore the validation this trial gives to other aspects of scancell's work - needle free delivery and the platform on which it is built, and other aspects all of which were raised by C7 some months ago.
It's amusing to see some names absent this morning (as you say Chester) - when it comes to celebrating this excellent RNS they would be very much in evidence with plenty to say had it been bad news. But it's good news, time and effort well spent, another good product in the shop window, and a newly appointed boss with his experienced and proven name over the shop door.

Could be either, depending when it actually took place, but would a 400k sell have hit the SP harder, where a buy was mopping up some of the sells of today and yesterday?

Crumbs - I think the idea is that you don't predict something and don't rule it out so you can say 'I never ruled it out' or 'I never said it would happen' - perfect hindsight for whatever comes about, especially as there is no 'doom squad.' We have been assured of that by the squad themselves, so it must be true (see how I did that? Covers all bases in any future scrutiny)
At the very worst, covidity appears to have validated many other arms of scancell science, but if you can engineer a temporary (and preferably significant) weakness in the sp, (or at least sow preemptive seeds for one) in the event of Covidity actually coming to a halt, then you're quids in - especially if you can post like the oracle of Delphi and cover all bases as you go. But then you and I are just happy clappers I suppose...

That explains the 11 trade today, and possibly the 27 as well. Shiver me timbers, and summon Roger the deck hand to my cabin.

Violindog, I think that would depend very much on the potential return a available of Covidity took off - as we all know, the numbers could be massive and the big pharmas have huge resources. But predicting what the next covidity will say is a bit like watching 'Bullseye' - it could be Dusty Bin, it could be the speedboat, or even the Vauxhall Chevette! Time will tell anyway.

A bit of a Sunday evening aside, for the amusement of those who have been labelled 'wild rampers' by the non existent doom club (aka the 'balanced') - looking through the raving conspiracy theorists and BONKERS posters WHO are old ENOUGH to know better, I strayed from there to the chat board of another "small bio" which was once held up by a poster here as showing the right way to do p.r. No names obviously, but the company in question has produced about 2 fifths of 3 eighths of fur call and has little to show beyond a small number of very dead trial participants who didn't get beyond phase 1, no significant cash and absolutely no institutional investors whatsoever. However, a poster on the dark side has confidently stated that they won't sell until that share hits 25 quid a pop. Now that represents a mere 2,380 bagger from its current price and an equivalent rise for scancell would put our sp at 464 quid each. So quite frankly, if you think you're ramping, you're going to have to up the game by a factor of several thousand for starters, and then hit the surgical spirit with a vengeance. Looking forward to the coming months with sclp, and feeling pretty level headed personally.

Rob23460 - when you said yesterday 'The question I ask myself why a minnow like Scancell?' in respect of M. Cossery, the same question applied to Redmile - massive fund, able to pick and choose who they invest in, certain to have done thorough due diligence, and choose Scancell who are genuinely tiny and don't waste effort on needless publicity, just developing cutting edge science. Building very interestingly IMO.

JohnnyB1 and Minor - thanks for that information, IMO an interesting sort of Venn diagram seems to be appearing. Sadly however, one has to acknowledge that in some eyes the factual information you have posted will be seen as 'hysterical ramping', whereas a comment to the effect of 'he's too old to be any use' will be hailed as 'balance.' But there is no 'doom club', naturally.

It's quietly amusing really - a younger candidate would be attacked with 'they're too young to have the experience or contacts in the post.' All at sea as ever.

Hardly the sort man who would be drawn to a 'lifestyle company.'
I imagine he has a few interesting names in his address book.